GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Rayont Inc (OTCPK:RAYT) » Definitions » FCF Margin %

Rayont (Rayont) FCF Margin % : 4.39% (As of Mar. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Rayont FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Rayont's Free Cash Flow for the three months ended in Mar. 2023 was $0.04 Mil. Rayont's Revenue for the three months ended in Mar. 2023 was $0.98 Mil. Therefore, Rayont's FCF Margin % for the quarter that ended in Mar. 2023 was 4.39%.

As of today, Rayont's current FCF Yield % is 0.00%.

The historical rank and industry rank for Rayont's FCF Margin % or its related term are showing as below:

RAYT' s FCF Margin % Range Over the Past 10 Years
Min: -64.59   Med: 0   Max: 0
Current: -64.59


RAYT's FCF Margin % is not ranked
in the Consumer Packaged Goods industry.
Industry Median: 2.255 vs RAYT: -64.59


Rayont FCF Margin % Historical Data

The historical data trend for Rayont's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rayont FCF Margin % Chart

Rayont Annual Data
Trend Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Jun22
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.39 -804.35 -4.43 -24.14 -125.01

Rayont Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.25 -290.92 -11.83 -1.55 4.39

Competitive Comparison of Rayont's FCF Margin %

For the Packaged Foods subindustry, Rayont's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rayont's FCF Margin % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Rayont's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Rayont's FCF Margin % falls into.



Rayont FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Rayont's FCF Margin for the fiscal year that ended in Jun. 2022 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2022 )/Revenue (A: Jun. 2022 )
=-3.549/2.839
=-125.01 %

Rayont's FCF Margin for the quarter that ended in Mar. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2023 )/Revenue (Q: Mar. 2023 )
=0.043/0.98
=4.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rayont FCF Margin % Related Terms

Thank you for viewing the detailed overview of Rayont's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Rayont (Rayont) Business Description

Traded in Other Exchanges
N/A
Address
228 Hamilton Avenue, 3rd Floor, Palo Alto, CA, USA, 94301
Rayont Inc is a clinical-stage life sciences company that holds the license for registering and commercializing Photosoft technology for the treatment of all cancers. This technology is an improved next-generation Photodynamic Therapy (PDT) that uses non-toxic photosensitizers and visible light in combination with oxygen to produce cytotoxic-reactive oxygen that kills malignant cells, shuts down tumors, and stimulates the immune system. It has been licensed in Australia, New Zealand, China, Malaysia, and Sub-Sahara Africa. It has generated revenue from digital learning solutions provided by Rayont Technologies.
Executives
Meng Leong Liew director 1313 N. GRAND AVE. #16, WALNUT CA 91789
Kha Foo Chin director, 10 percent owner, officer: President, Treasurer ROOM 1217 NORTH TOWER, CONORDIA PLAZA, NO 1 SCIENCE MUSEUM RD., TSIM SHA TSUI E, KOWLOON K3 NA